Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KraneShares Hang Seng TECH Index ETF (KTEC) vs Eli Lilly And Co (LLY) Price & Performance

KraneShares Hang Seng TECH Index ETFTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

KraneShares Hang Seng TECH Index ETF vs Eli Lilly And Co — how do they compare? KraneShares Hang Seng TECH Index ETF trades at $13.27, while Eli Lilly And Co trades at $1,172.09 (market cap $1.02T). The key difference: Eli Lilly And Co pays a 0.6% dividend while KraneShares Hang Seng TECH Index ETF pays none. Which is the better fit depends on your goals.

KTECLLY
Sector
Sector/ThematicHealth
52-Week High
$19.51$1.24K
52-Week Low
$12.00$625.65
Market Cap
$1.02T
Enterprise Value
$1.06T
Dividend Yield
0.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KraneShares Hang Seng TECH Index ETF

KTEC stock is trading at $13.28, up 2.23% today, showing positive momentum. The stock's technical picture indicates recent strength, though key financial ratios including P/E, P/S, and profitability metrics are currently unavailable for analysis. No recent earnings data or business developments are accessible to provide fundamental context.

Investment outlook remains unclear due to insufficient financial data. The primary opportunity lies in the stock's recent price appreciation, while risks include limited transparency on company fundamentals and the absence of analyst coverage or institutional positioning data to validate current valuation levels.

Eli Lilly And Co

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About KraneShares Hang Seng TECH Index ETF

KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.

Read more on KTEC

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY